Hartley-Asp B - Search Results

1

Phase I clinical and pharmacologic trial of intravenous estramustine phosphate.

Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B. Hudes G, et al. Among authors: hartley asp b. J Clin Oncol. 2002 Feb 15;20(4):1115-27. doi: 10.1200/JCO.2002.20.4.1115. J Clin Oncol. 2002. PMID: 11844837 Clinical Trial.

2

Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug.

Tew KD, Glusker JP, Hartley-Asp B, Hudes G, Speicher LA. Tew KD, et al. Pharmacol Ther. 1992 Dec;56(3):323-39. doi: 10.1016/0163-7258(92)90023-s. Pharmacol Ther. 1992. PMID: 1301594 Review.

3

Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.

Walz PH, Björk P, Gunnarsson PO, Edman K, Hartley-Asp B. Walz PH, et al. Among authors: hartley asp b. Clin Cancer Res. 1998 Sep;4(9):2079-84. Clin Cancer Res. 1998. PMID: 9748122

4

Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.

Hartley-Asp B, Hansson K, Vibe-Petersen J, Hansen HH, Polacek J, Ellman M, Gunnarsson PO. Hartley-Asp B, et al. Cancer Chemother Pharmacol. 1996;38(4):309-16. doi: 10.1007/s002800050488. Cancer Chemother Pharmacol. 1996. PMID: 8674152

5

Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).

Hartley-Asp B, Gunnarsson PO. Hartley-Asp B, et al. J Urol. 1982 Apr;127(4):818-22. doi: 10.1016/s0022-5347(17)54057-4. J Urol. 1982. PMID: 7069864

6

Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L.

Kruse E, Johansson SA, Hartley-Asp B, Gunnarsson PO. Kruse E, et al. Biochem Pharmacol. 1988 Aug 15;37(16):3161-7. doi: 10.1016/0006-2952(88)90315-2. Biochem Pharmacol. 1988. PMID: 3401247

7

Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.

Kelly WK, Zhu AX, Scher H, Curley T, Fallon M, Slovin S, Schwartz L, Larson S, Tong W, Hartley-Asp B, Pellizzoni C, Rocchetti M. Kelly WK, et al. Among authors: hartley asp b. Clin Cancer Res. 2003 Jun;9(6):2098-107. Clin Cancer Res. 2003. PMID: 12796374 Clinical Trial.

8

Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.

Solit DB, Morris M, Slovin S, Curley T, Schwartz L, Larson S, Kattan MW, Hartley-Asp B, Scher HI, Kelly WK. Solit DB, et al. Among authors: hartley asp b. Cancer. 2003 Nov 1;98(9):1842-8. doi: 10.1002/cncr.11754. Cancer. 2003. PMID: 14584065 Free article. Clinical Trial.

9

Interaction of estramustine with tubulin isotypes.

Laing N, Dahllöf B, Hartley-Asp B, Ranganathan S, Tew KD. Laing N, et al. Among authors: hartley asp b. Biochemistry. 1997 Jan 28;36(4):871-8. doi: 10.1021/bi961445w. Biochemistry. 1997. PMID: 9020786

10

Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo.

Eklöv S, Nilsson S, Larson A, Björk P, Hartley-Asp B. Eklöv S, et al. Prostate. 1992;20(1):43-50. doi: 10.1002/pros.2990200106. Prostate. 1992. PMID: 1736276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters